A Quick Take On Odyssey Therapeutics, Inc. Odyssey Therapeutics, Inc. (ODTX) has filed to raise $100 million in an IPO of its ordinary shares, according to SEC S-1 registration information.

Perspective Therapeutics reports no dose-limiting toxicities or severe adverse events in Phase 1/2a trial of [212Pb]VMT-α-NET. Anti-tumor activity observed: 1 confirmed response (17 weeks), 2 ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval ...

Despite the competitive threat posed by Eli Lilly’s acquisition of Scorpion Therapeutics’ STX-478, which has shown promising efficacy in several cancer types, Relay Therapeutics’ RLY-2608 ...

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...

However, for Stipe, things weren’t so easy. He struggled with writer’s block and the death of a close friend. But as he gained his footing, tragedy arrived once again. Actor River Phoenix’s ...

R.E.M.’s Michael Stipe has encouraged people to boycott Facebook and Instagram over their role in “helping advance the far right in America”. The singer has called for people to log out from ...

R.E.M. frontman Michael Stipe has encouraged people to boycott Facebook, Instagram and all platforms owned by Meta over their role in “helping advance the far right in America.” The singer ...

Dyne Therapeutics Inc. 4.43% $1.38B ...